Trial Profile
Oxytocin in Individuals With Spectrum Autism Disorders
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- Acronyms OxytocinASD
- 03 May 2019 Status changed from active, no longer recruiting to completed.
- 04 May 2018 Planned End Date changed from 29 Jul 2017 to 15 May 2018.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.